Tatlong bakuna kontra COVID-19 nasa 2nd phase na ng trial sa China

By Dona Dominguez-Cargullo April 28, 2020 - 01:02 PM

Tatlo bakuna kontra COVID-19 ang nasa ikalawang bahagi na ng clinical trial sa China.

Sasailalim pa ang nasabing mga bakuna sa mas masusing research para matiyak ang kaligtasan nito at ang pagiging epektibo.

Sa ngayon mayroong limang uri ng bakuna na binubuo sa China.

Sumasailalim na rin sa testing sa China ang plasma transfusion, stem cell therapy at monoclonal antibodies para panlaban sa COVID-19.

 

 

 

 

 

TAGS: China, clinical trial, covid vaccine, China, clinical trial, covid vaccine

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.